Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Earnings

Norwegian Hydrogen Specialist Nel Navigates Challenging Market Conditions

Robert Sasse by Robert Sasse
November 1, 2025
in Earnings, European Markets, Hydrogen, Renewable Energy
0
Nel ASA Stock
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Nel ASA, the Norwegian hydrogen technology company, finds itself navigating turbulent market conditions as its latest quarterly results reveal a complex financial landscape. The third-quarter figures present a tale of two narratives: substantial improvements in profitability stand in stark contrast to significant declines in both revenue and new order intake.

Financial Performance: A Mixed Picture

The company reported revenues of 303 million Norwegian kroner, representing a 17 percent year-over-year decrease. However, a sequential comparison reveals a more encouraging trend, with sales climbing 74 percent from the previous quarter. On the profitability front, Nel demonstrated marked improvement, with EBITDA reaching negative 37 million NOK compared to negative 90 million NOK during the same period last year. The net loss also narrowed considerably, shrinking from 115 million to 85 million NOK year-over-year.

Order Book Contraction Raises Concerns

Perhaps the most concerning aspect of the report was the dramatic contraction in new business. Order intake plummeted to just 57 million NOK, representing a 64 percent decline compared to the previous year. The company’s order backlog similarly diminished, contracting 47 percent over twelve months to stand at 984 million NOK. These figures reflect the cautious investment sentiment currently prevailing within the green hydrogen sector.

Despite these operational headwinds, Nel maintains a solid financial foundation. The company possesses liquid assets of approximately 1.8 billion NOK, providing a buffer against current market challenges. Nevertheless, investors on the Oslo Stock Exchange responded negatively to the mixed report, sending shares lower.

Should investors sell immediately? Or is it worth buying Nel ASA?

Regulatory Landscape Impedes Growth

Company leadership pointed to a “challenging macroeconomic environment” and an electrolyzer market developing more slowly than anticipated. Particularly stringent regulatory barriers across European markets are currently hampering the advancement of hydrogen production initiatives.

In response to these market dynamics, Nel is intensifying its focus on technological innovation. The company is developing a new pressurized alkaline solution scheduled for market release in the first half of 2026, which aims to substantially reduce hydrogen project costs. Simultaneously, Nel is expanding its collaborative efforts with industrial partners including General Motors, Reliance, and Samsung E&A.

Future Prospects and Market Sentiment

Management maintains an optimistic outlook despite the sluggish order intake. They note that Front-End Engineering and Design (FEED) activities continue at relatively robust levels, suggesting potential future orders should market conditions improve.

Market analysts continue monitoring Nel’s progress, with Kepler Cheuvreux recently raising its price target for the company’s shares. The investment community now awaits signals of market recovery and the successful implementation of new technologies in 2026. The company’s next quarterly report is scheduled for release on March 4, 2026.

Ad

Nel ASA Stock: Buy or Sell?! New Nel ASA Analysis from February 7 delivers the answer:

The latest Nel ASA figures speak for themselves: Urgent action needed for Nel ASA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Nel ASA: Buy or sell? Read more here...

Tags: Nel ASA
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock
Consumer & Luxury

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock
Earnings

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Next Post
BYD Stock

BYD Shares Under Pressure Following Steep Profit Decline

Ethereum Stock

Ethereum at a Critical Juncture: Key Decision Point Approaches

Metaplanet Stock

Japanese Firm Metaplanet Pioneers Bitcoin-Backed Share Buyback Strategy

Recommended

Fiserv Stock

Fiserv Shares Struggle to Gain Traction Amid Investor Doubts

3 weeks ago
Cooper-Standard Stock

Cooper-Standard Shares Plunge on Disappointing Earnings Report

3 months ago
Volatus Aerospace Stock

Volatus Aerospace Expands Defense and Environmental Technology Operations

5 months ago
FCBC stock news

Symmetry Partners LLC Acquires Significant Position in Carnival Co. & plc, Expresses Optimism for Future Growth

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Trending

Embecta Stock
Earnings

Embecta’s Q1 Performance Outpaces Analyst Forecasts

by Rodolfo Hanigan
February 7, 2026
0

Medical device company Embecta reported financial results for the first quarter of fiscal year 2026 on Thursday,...

Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
Deluxe Stock

Deluxe Stock Gains Momentum on Successful Fintech Transition

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test
  • Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com